Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1111-1116, May 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steeves, R. A.
Right arrow Articles by Avila, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steeves, R. A.
Right arrow Articles by Avila, L.

Enhancement of Spleen Focus Formation and Virus Replication in Friend Virus-infected Mice1

Richard A. Steeves, Edwin A. Mirand, Suteera Thomson and Luis Avila

Department of Viral Oncology, Roswell Park Memorial Institute, Buffalo, New York 14203

Spleen focus formation, induced by a member [spleen focus-forming virus (SFFV)] of the Friend virus complex, was enhanced in mice that had been infected 2 days previously with Newcastle disease virus or lactic dehydrogenase-elevating virus. Enhancement was also observed in mice treated with erythropoietin or maintained in 10 percent oxygen for 48 hours before SFFV infection. Sublethally irradiated mice were able to synthesize 30 times as much SFFV after treatment with S. typhosa endotoxin. Evidence is presented which indicates that these treatments exert their effects, at least in part, by increasing the number or susceptibility of target cells for SFFV. The data are consistent with the hypothesis that a major portion of the target cells for SFFV are primitive erythroid cells, possibly erythropoietin-sensitive cells.

1 This investigation was supported in part by the National Cancer Institute (USPHS research grants, CA-08847-02 and CA-07745-04), and by the United Health Foundation of Western New York (Grant G-R-68-RP-14).

Received 10/10/68. Accepted 12/22/68.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Marques, I. Antunes, U. Eksmond, J. Stoye, K. Hasenkrug, and G. Kassiotis
B Lymphocyte Activation by Coinfection Prevents Immune Control of Friend Virus Infection
J. Immunol., September 1, 2008; 181(5): 3432 - 3440.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Robertson, R. J. Messer, A. B. Carmody, R. S. Mittler, C. Burlak, and K. J. Hasenkrug
CD137 Costimulation of CD8+ T Cells Confers Resistance to Suppression by Virus-Induced Regulatory T Cells
J. Immunol., April 15, 2008; 180(8): 5267 - 5274.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Robertson, C. G. Ammann, R. J. Messer, A. B. Carmody, L. Myers, U. Dittmer, S. Nair, N. Gerlach, L. H. Evans, W. A. Cafruny, et al.
Suppression of Acute Anti-Friend Virus CD8+ T-Cell Responses by Coinfection with Lactate Dehydrogenase-Elevating Virus
J. Virol., January 1, 2008; 82(1): 408 - 418.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.